• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲癌症研究与治疗组织QLQ-BR23量表和FACT-B量表用于评估乳腺癌患者的生活质量:一项文献综述

EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review.

作者信息

Nguyen Jasmine, Popovic Marko, Chow Edward, Cella David, Beaumont Jennifer L, Chu Dominic, DiGiovanni Julia, Lam Henry, Pulenzas Natalie, Bottomley Andrew

机构信息

Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.

出版信息

J Comp Eff Res. 2015 Mar;4(2):157-66. doi: 10.2217/cer.14.76.

DOI:10.2217/cer.14.76
PMID:25825844
Abstract

BACKGROUND

This study aims to compare the development, characteristics and validity of two widely used tools in the breast cancer population, the EORTC QLQ-BR23 and the FACT-B.

METHODS

A literature search was conducted using Ovid MEDLINE, OLDMEDLINE, Embase, Embase Classic and the Cochrane Central Register of Controlled Trials to identify relevant studies.

RESULTS

Both tools were found to be reliable and valid. The QLQ-BR23 focuses on physical function, whereas the FACT-B emphasizes emotional well-being. Scoring, item format, organization and response options differ between questionnaires.

CONCLUSION

Overall, both questionnaires are effective in assessing breast cancer-specific quality of life. Clear similarities and differences between the two tools exist. Decision-making between the questionnaires should be based on the purpose and design of the study.

摘要

背景

本研究旨在比较两种在乳腺癌人群中广泛使用的工具,即欧洲癌症研究与治疗组织生活质量问卷-乳腺癌模块23(EORTC QLQ-BR23)和癌症治疗功能评价系统-乳腺癌量表(FACT-B)的发展、特点及效度。

方法

通过检索Ovid MEDLINE、OLDMEDLINE、Embase、Embase Classic以及Cochrane对照试验中心注册库来查找相关研究。

结果

发现这两种工具均可靠且有效。QLQ-BR23侧重于身体功能,而FACT-B强调情感幸福。问卷在评分、条目格式、结构及回答选项方面存在差异。

结论

总体而言,这两种问卷在评估乳腺癌特异性生活质量方面均有效。两种工具存在明显的异同。问卷之间的决策应基于研究目的和设计。

相似文献

1
EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review.欧洲癌症研究与治疗组织QLQ-BR23量表和FACT-B量表用于评估乳腺癌患者的生活质量:一项文献综述
J Comp Eff Res. 2015 Mar;4(2):157-66. doi: 10.2217/cer.14.76.
2
Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.用于结直肠癌患者的FACT-C、欧洲癌症研究与治疗组织核心生活质量问卷CR38和核心生活质量问卷CR29生活质量问卷比较:一项文献综述
Support Care Cancer. 2016 Aug;24(8):3661-8. doi: 10.1007/s00520-016-3270-7. Epub 2016 May 18.
3
Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.欧洲癌症研究与治疗组织(EORTC)QLQ-C30和BR23模块土耳其语版本在乳腺癌患者中的验证
Asian Pac J Cancer Prev. 2011;12(5):1283-7.
4
Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.希腊 EORTC QLQ-C30 和 QLQ-BR23 量表用于测量乳腺癌患者健康相关生活质量的有效性。
Eur J Cancer Care (Engl). 2011 May;20(3):354-61. doi: 10.1111/j.1365-2354.2009.01170.x.
5
Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23).欧洲癌症研究与治疗组织(EORTC)乳腺癌特异性生活质量问卷(EORTC QLQ-BR23)韩文版的跨文化应用。
Support Care Cancer. 2004 Jun;12(6):441-5. doi: 10.1007/s00520-004-0632-3. Epub 2004 Apr 16.
6
Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.验证 EORTC QLQ-C30 和 BR23 问卷的墨西哥西班牙语版本,以评估墨西哥乳腺癌女性的健康相关生活质量。
Eur J Cancer Care (Engl). 2012 Sep;21(5):684-91. doi: 10.1111/j.1365-2354.2012.01336.x. Epub 2012 Feb 14.
7
Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23.测量南亚地区乳腺癌特异性健康相关生活质量:欧洲癌症研究与治疗组织QLQ-BR23僧伽罗语版本的心理测量特性
Qual Life Res. 2008 Aug;17(6):927-32. doi: 10.1007/s11136-008-9359-9. Epub 2008 May 24.
8
Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review.原发性脑癌患者的欧洲癌症研究与治疗组织QLQ-BN20和FACT-Br生活质量问卷比较:一项文献综述
Support Care Cancer. 2014 Sep;22(9):2593-8. doi: 10.1007/s00520-014-2352-7.
9
Comparison of the EORTC STO-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer.欧洲癌症研究与治疗组织(EORTC)STO - 22问卷与癌症治疗功能评估通用量表(FACT - Ga)用于胃癌患者生活质量问卷的比较。
Ann Palliat Med. 2016 Jan;5(1):13-21. doi: 10.3978/j.issn.2224-5820.2016.01.02.
10
Health-related quality of life in women with breast cancer: a review of measures.乳腺癌患者的健康相关生活质量:评估工具的综述。
BMC Cancer. 2022 Jan 15;22(1):66. doi: 10.1186/s12885-021-09157-w.

引用本文的文献

1
Quality of life during the COVID-19 pandemic and survival outcomes among breast cancer survivors.新冠疫情期间乳腺癌幸存者的生活质量及生存结局
Breast Cancer Res Treat. 2025 Aug 15. doi: 10.1007/s10549-025-07808-1.
2
Cross-Cultural Adaptation of the Breast Cancer and Lymphedema Symptom Experience Index in Bengali.《乳腺癌与淋巴水肿症状体验指数在孟加拉语中的跨文化适应性研究》
J Transcult Nurs. 2025 Jun 28;36(5):10436596251345338. doi: 10.1177/10436596251345338.
3
Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China.
CDK4/6抑制剂治疗激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌的安全性及生活质量:一项中国多中心横断面调查
BMC Cancer. 2025 May 27;25(1):951. doi: 10.1186/s12885-025-14223-8.
4
How family support alleviates death anxiety in breast cancer patients: the mediating role of meaning in life.家庭支持如何减轻乳腺癌患者的死亡焦虑:生命意义的中介作用。
Front Public Health. 2025 Apr 1;13:1567485. doi: 10.3389/fpubh.2025.1567485. eCollection 2025.
5
Impact of early multidisciplinary team interventions on dietary management behavior in breast cancer patients: a pilot randomized controlled trial.早期多学科团队干预对乳腺癌患者饮食管理行为的影响:一项试点随机对照试验。
BMC Cancer. 2025 Apr 15;25(1):699. doi: 10.1186/s12885-025-13991-7.
6
Perspectives on Quality of Life in Women with Breast Cancer.乳腺癌女性生活质量的相关观点
Indian J Palliat Care. 2024 Oct-Dec;30(4):347-352. doi: 10.25259/IJPC_37_2024. Epub 2024 Nov 15.
7
Psychometric Evaluation of the Chinese Version of the Vulvovaginal Symptom Questionnaire in Women With Breast Cancer.乳腺癌女性外阴阴道症状问卷中文版的心理测量学评估
J Adv Nurs. 2025 Jul;81(7):3904-3928. doi: 10.1111/jan.16584. Epub 2024 Oct 30.
8
Clinical Pharmacist-Led Interventions for Improving Breast Cancer Management-A Scoping Review.临床药师主导的干预措施在改善乳腺癌管理中的应用:一项范围综述。
Curr Oncol. 2024 Jul 25;31(8):4178-4191. doi: 10.3390/curroncol31080312.
9
Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial).通过疼痛神经科学教育改善早期三阴性乳腺癌患者的赋权、疼痛控制和生活质量:一项前瞻性队列试验研究方案(EMPOWER试验)
J Pers Med. 2024 Jul 1;14(7):711. doi: 10.3390/jpm14070711.
10
Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention.满足墨西哥乳腺癌女性的未满足需求:数字化电子患者报告结局干预的非随机试点研究。
BMJ Open. 2024 Jun 21;14(6):e087240. doi: 10.1136/bmjopen-2024-087240.